Price is pumped today to $45.55. That makes the offering at $42.50 look like a 2% discount. They moved 2,100,000 shares today this way including AH. Its perfectly executed from the perspective of the company raising money...but the fine print is that they are raising the money at the expense of the suckers buying at this price.
Wont be long before analysts downgrade this thing at this price. $1.4B market cap now w/ additional share dilution at these prices? They have YEARS to go even if their product DOES work exactly as they hope it does in Phase II and Phase III trials. That is all a BIG if. On top of that, we know that like most other developing biotechs, a regularly yearly dilution to raise more funds is most likely.
i mean WHO CARES if they have a product or not and if they are raising money at the expense of suckers as you call it???
as long as stock keeps going up (for WHATEVER reason, good bad or ugly) you can make money trading it as daytrades or swing trades. NOTHING ELSE MATTERS. heck yah, make money of a pig too, it is possible